Research applications for TB-500 include: Skeletal muscle fiber regeneration Chemotaxis of myoblasts, the precursor cells involved in muscle repair Systemic anti-inflammatory modulation Wound healing across skin and connective tissue Because TB-500 circulates systemically after administration, preclinical models suggest it can reach multiple injury sites at once rather than acting only where it is applied
However, only 1-2 pumps of the cream are needed
It has been explored for its ability to: Support tissue repair Reduce inflammation Promote blood vessel formation (angiogenesis) Enhance collagen production These effects make it relevant in conditions involving joints, tendons, ligaments, nerves, and the gut
Key distinction: BPC-157 is not a steroid, not a hormone, and not a growth hormone releasing peptide
It is being evaluated through Eli Lilly's Phase 3 TRIUMPH program
Abstract Purpose of Review This scoping review aims to evaluate the molecular mechanisms, therapeutic potential, and safety concerns of Body Protective Compound-157 (BPC-157) in the context of musculoskeletal healing